If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.295    0.00 (0.00%)
Bid:
0.29
Ask:
0.30
Spread: 0.01 (3.448%)
Market Cap: £22.94m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Haydale selected for Innovate UK Scaleup Programme

22 Jan 2024 07:00

RNS Number : 1789A
Haydale Graphene Industries PLC
22 January 2024
 

RNS-Reach

 

For immediate release

22 January 2024

 

 

Haydale Graphene Industries plc

 

('Haydale')

 

Haydale Graphene Industries selected for Innovate UK Scaleup Programme

 

Haydale (AIM: HAYD) To further accelerate commercialisation of its unique, patented, plasma functionalised formulations in various industries, and following a rigorous three stage screening process, Haydale has secured a prestigious support service from Innovate UK.

 

The Scaleup Programme is provided by Innovate UK EDGE, the innovation agency's national business growth and scaling service. The service, provided in the form of strategic support, advice and guidance is designed to empower ambitious innovation-focused SMEs in every sector and from seed to scaling stage, to grow and become highly successful through coaching and mentorship.

 

The Programme is designed to support highly innovative, ambitious, high-growth oriented companies already on their scaling journey, whose innovations or business models can disrupt an existing market, and who are establishing or already implementing their international markets strategy.

 

Commenting on the successful selection by Innovate UK, Haydale Chief Executive Officer Keith Broadbent said:

 

"We have spent a significant amount of time and resources on developing our unique patented, proprietary plasma technology. We are now delighted to have secured the help of Innovate UK EDGE on our scale up journey, continue to grow revenues and build on the existing relationships with world leading partners we are now working with."

 

Deputy Director Business Growth at Innovate UK, Maxine Adam, said:

 

"We are looking forward to working with the Haydale team and are confident we can show just how much value this programme can add. The inputs are varied and blend strategic thinking with invaluable hands-on tactical guidance, to create outcomes that deliver real commercial advantage. It's a pleasure working with the Haydale Directors at this pivotal time for their business."

 

- Ends -

For further information:

Haydale Graphene Industries plc

Keith Broadbent, CEO Tel: +44 (0) 1269 842946

Mark Bolt, Sales & Marketing Manager Tel: +44 (0) 1269 507026

 

Cavendish Capital Markets (Nominated Adviser & Broker)

Julian Blunt / Edward Whiley, Corporate Finance Tel: +44 (0) 20 7220 0500

Andrew Burdis, ECM

 

Notes to Editors

 

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale can deliver improvements in electrical, thermal, and mechanical properties, as well as toughness through its state-of-the-art functionalisation. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan, and China and operates from five sites in the UK, USA, and the Far East.

 

For more information please visit: www.haydale.com

 

LinkedIn:Haydale-ltdTwitter / X: @haydalegraphene

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABPMBTMTMBBLI
Date   Source Headline
24th Jun 20267:00 amRNSInterim Results
11th Jun 20267:00 amRNSContract Win
21st May 20267:05 amRNSProposed Commercial Relationship
8th Apr 20265:18 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSNew Contract Signed
26th Mar 20263:39 pmRNSResult of AGM
6th Mar 20261:31 pmRNSInvestor Presentation via Investor Meet Company
2nd Mar 20267:00 amRNSStrategic Digital Infrastructure Partnership
17th Feb 20267:00 amRNSFinal Results and Post-Period Trading Update
11th Feb 20267:00 amRNSNotice of Annual Results
30th Jan 20269:45 amRNSTotal Voting Rights
22nd Jan 20264:54 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSHolding(s) in Company
21st Jan 202612:31 pmRNSHolding(s) in Company
15th Jan 20265:01 pmRNSHolding(s) in Company
15th Jan 20262:44 pmRNSChange of Name
12th Jan 20267:00 amRNSCompletion of Acquisition
9th Jan 20266:19 pmRNSDirector/PDMR Dealings
8th Jan 20261:59 pmRNSHolding(s) in Company
8th Jan 20261:55 pmRNSHolding(s) in Company
6th Jan 20262:45 pmRNSResult of General Meeting and Total Voting Rights
22nd Dec 20252:08 pmRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSHolding(s) in Company
16th Dec 202512:45 pmRNSResult of Retail Offer
15th Dec 20259:14 amRNSResult of Accelerated Bookbuild
12th Dec 20257:05 amRNSRetail Offer
12th Dec 20257:00 amRNSProposed Fundraise and Acquisition
2nd Dec 20257:00 amRNSCommercial Update
30th Oct 202510:45 amRNSExpansion of Commercial Platform
23rd Oct 20257:00 amRNSContract Wins
11th Sep 20257:00 amRNSStrategic Collaboration and Trading Update
8th Aug 20257:00 amRNSGrant of Share Options and PDMR Dealings
11th Jul 20258:21 amRNSHolding(s) in Company
30th Jun 20253:14 pmRNSHolding(s) in Company
26th Jun 20252:00 pmRNSSubscriptions, Director Dealings & Issue of Equity
12th Jun 20252:12 pmRNSTrading Update
23rd Apr 20255:22 pmRNSDirectorate Change
17th Apr 202510:46 amRNSCorrection: Haydale US Sales Process Update
17th Apr 20257:00 amRNSHaydale US Sales Process Update
2nd Apr 20257:00 amRNSHaydale Achieves CE Certification
13th Mar 20252:15 pmRNSSubscription, Director Dealings and TVR
13th Mar 20257:00 amRNSInterim Results
7th Mar 202510:18 amRNSHaydale US sales process update
10th Feb 20257:00 amRNSHaydale US placed into insolvency process
30th Dec 20245:20 pmRNSReplacement: Result of AGM
30th Dec 202412:48 pmRNSResult of AGM
23rd Dec 20247:05 amRNSDisposal of Korean Subsidiary
23rd Dec 20247:00 amRNSBusiness Review and Appointment of CEO
6th Dec 20247:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20249:44 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.